Both domestically and globally, the medical device and pharmaceutical business is a unique market environment. Advanced management capability is required, in addition to a deep understanding of the industry. NRI provides this deep understanding, through various consultation services, to legacy and new entrants. We help establish management strategies based on the results of many years of study of social security systems and the extensive understanding of characteristics of international market sectors.
Health technology assessment (HTA)
Due to increasing medical expenses, adoption of Health Technology Assessment (HTA) of medical policies is becoming commonplace around the world. The British government was among the first in the world to adopt HTA, and while it’s argued to be a hurdle for new drug approval, it serves as a basis for lowering drug prices. In order to protect the values of their own products, pharmaceutical companies have to establish a system to respond to HTA.
NRI conducts intensive studies globally, evaluating infrastructure and system using our expert analysis. Using our results from these studies, NRI provides consulting services to pharmaceutical companies and medical equipment manufacturers around the world in order to provide organizational measures for HTA introduction, as well as to the actual evaluation operations.
Business and growth strategies for the pharmaceutical industry
Pharmaceutical companies around the world have suffered from significant sales volume decline due to the expiration of large-scale drug patents. Industry leaders have successfully used collaboration and M&A to renew their pipelines. NRI supports pharmaceutical firms around the world in addressing critical business themes such as sales and cost structure reforms, lifecycle management of existing products, and overseas market development.
Business and growth strategies for the medical device (equipment and materials) industry
The medical device market is expected to grow to the $47 billion mark worldwide by 2018, attracting attention from investors due to the generally higher profitability. However, while the market is attractive, it needs to innovate amid the drastic changes in the market environment, such as an aging global population, increase in chronic diseases, and expansion of demand in emerging countries.
The medical device industry is complicated, with legacy competition rules created by industry leaders and a unique cost structure that other manufacturing industries have difficulty comprehending. Deep industry understanding on management strategies for innovation is needed in order to develop sustainable business growth.
Through consistent support across the corporate structure, NRI redesigns organizations to match the uniqueness of the business segment and supports formulation and execution of measures to enhance competitiveness of our clients.
Projects NRI is Involved in the Healthcare and Welfare Fields
- Ministry of Economy, Trade, and Industry: Promotion of Internationalization of Medical Equipment and Services
- Ministry of Health, Labor, and Welfare: Study on the Policies of Facilitating the Foundation of Future Nursing Care Services
- Ministry of Internal Affairs and Communications: Promotion of the Information Platform for Home Medical Care and Nursing Care